In this issue of PET Clinics, guest editors Drs. Cristina Nanni, Paolo Castellucci, Stefano Fanti, and Neeta Pandit-Taskar bring their considerable expertise to the topic of Novel PET Imaging Techniques in the Management of Hematological Malignancies. Top experts in the field discuss the latest radiotracers for lymphoma and myeloma, novel quantitative imaging techniques, radioligand therapies, total body PET imaging; and more.
2-deoxy-2-[18F]FDG PET Imaging for Therapy Assessment in Hodgkin’s and Non-Hodgkin Lymphomas New PET Tracers for Lymphoma Radioligand Therapy in Lymphoma: Past, Present, and Future Long-Axial Field-of-View PET Imaging in Patients with Lymphoma: Challenges and Opportunities FDG-PET/CT Imaging in Chimeric Antigen Receptor-Engineered T-Cell Treatment in Patients with B-Cell Lymphoma: Current Evidence New PET Tracers for Symptomatic Myeloma Symptomatic Myeloma: PET, Whole-Body MR Imaging with Diffusion-Weighted Imaging or Both Applications of 18F-Fluorodesoxyglucose PET Imaging in Leukemia Role of Novel Quantitative Imaging Techniques in Hematological Malignancies Lymphoma: The Added Value of Radiomics, Volumes and Global Disease Assessment PET Imaging in Chimeric Antigen Receptor T-Cell Trafficking
Comments (0)
Your review appreciation cannot be sent
Report comment
Are you sure that you want to report this comment?
Report sent
Your report has been submitted and will be considered by a moderator.